Using clinical and genetic data to predict pulmonary hypertension in bronchopulmonary dysplasia.

These findings demonstrate that ROC predictive modeling of pulmonary hypertension in bronchopulmonary dysplasia improves with inclusion of both genotypic and phenotypic data. Further refinement of these types of models could facilitate the implementation of precision medicine approaches to pulmonary hypertension in bronchopulmonary dysplasia. This article is protected by copyright. All rights reserved.